Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Revalesio's RNS60 shows promise in treating Alzheimer's disease and other dementias Revalesio and Rush University Medical Center's Department of Neurological Sciences published findings from two research studies that demonstrate the potential for RNS60 to treat Alzheimer's disease and other forms of dementia by protecting neuronal function, restoring neuronal connections and promoting neuronal plasticity.
Contract Research & Services > Contract Research > News
Cannabics Pharmaceuticals receives Cannabinoid R&D lab certification in Israel Cannabics Pharmaceuticals has received Government Certification from the Ministry of Health in Israel for the establishment of an advanced R&D laboratory dedicated to medical research in the field of cannabinoid science.
Contract Research & Services > Contract Research > News AstraZeneca, Cambridge University collaborate to research on neurodegenerative diseases By PBR Staff Writer
AstraZeneca, along with its subsidiary MedImmune, has entered into four new collaborations with the University of Cambridge.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Sponsor and CRO Pharmacovigilance Alliances
| By PRA Health Sciences
Outsourcing pharmacovigilance activities is a standard business practice in a rapidly expanding market segment. In the past, outsourced safety services were limited due to concerns about confidentiality, data security and liability in cases of regulatory non-compliance, which are all still important considerations today.
Contract Research & Services > Contract Research > White Papers
Translating Cancer Genomics Into a Personalised Approach for Cancer Patients
| By PRA Health Sciences
This white paper provides a brief history of oncology genomics, including development, uses in improving patient care, current achievements and challenges and the future direction of cancer genomics.
Contract Research & Services > Contract Research > White Papers
AstraZeneca, Cambridge University collaborate to research on neurodegenerative diseases
By PBR Staff Writer
AstraZeneca, along with its subsidiary MedImmune, has entered into four new collaborations with the University of Cambridge.
Contract Research & Services > Contract Research > News
INC Research to perform FDA due diligence audit of regulatory documents for Provectus
Provectus Biopharmaceuticals, a development-stage oncology and dermatology biopharmaceutical company, has retained INC Research, a leading, global Phase I to IV contract research organization, to conduct an FDA due diligence audit of its regulatory documents for PH-10 and PV-10.
Contract Research & Services > Contract Research > News
Veristat, Molecular Templates enter into preferred provider agreement for refractory non-Hodgkin’s B-Cell Lymphoma trial
Veristat, a full service Clinical Research Organization (CRO), announced that Molecular Templates, a venture-backed biopharmaceutical company that develops next-generation immunotoxins for the treatment of cancer and other serious diseases, has entered into a Preferred Provider Agreement with Veristat.
Contract Research & Services > Contract Research > News
Dynavax begins Phase I/II trial of lymphoma treatment TLR-9
By PBR Staff Writer
US-based biopharmaceutical firm Dynavax Technologies has started a Phase I/II clinical trial (LYM-01) of an investigational Toll-like receptor (TLR) 9 agonist, SD-101, in adults with untreated low-grade B-cell lymphoma.
Contract Research & Services > Contract Research > News
CytRx begins operations at new discovery laboratory in Germany
By PBR Staff Writer
CytRx, a US-based biopharmaceutical research and development firm, has started operations at its new discovery laboratory in Freiburg, Germany.
Contract Research & Services > Contract Research > News
AbbVie announces late-breaking results from Phase III trial of HUMIRA in Hidradenitis Suppurativa patients
AbbVie announced new results from PIONEER II, a pivotal Phase III study, demonstrating the effect of HUMIRA (adalimumab) in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules.
Contract Research & Services > Contract Research > News
Pfenex partners with PATH to improve vaccine production
By PBR Staff Writer
US-based biotechnology firm Pfenex has started a multi-product research program with PATH, a global health nonprofit organization, as part of an initiative to improve vaccine production.
Contract Research & Services > Contract Research > News
Beijing Sihuan Pharmaceutical to collaborate with AMMS for anti-Ebola drug jk-05
Sihuan Pharmaceutical Holdings Group subsidiary Beijing Sihuan Pharmaceutical has entered into a collaborative development agreement with the Institute of Microbiology and Epidemiology of the Academy of Military Medical Sciences (AMMS) for anti-Ebola drug jk-05.
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250